Abstract
A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods. The best compound in the series showed an IC50 value of 0.4 μM. A docking study was conducted for compound (S)-10n in order to investigate its binding interactions with MMP-1. The structure-activity relationships (SAR) were also briefly discussed. Useful SAR was established which provides important guidelines for the design of future generations of potent inhibitors against MMP-1.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acrylates / chemical synthesis
-
Acrylates / chemistry
-
Acrylates / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Design
-
Humans
-
Matrix Metalloproteinase 1 / metabolism*
-
Matrix Metalloproteinase Inhibitors / chemical synthesis
-
Matrix Metalloproteinase Inhibitors / chemistry
-
Matrix Metalloproteinase Inhibitors / pharmacology*
-
Models, Molecular
-
Molecular Structure
-
Phenylpropionates / chemical synthesis
-
Phenylpropionates / chemistry
-
Phenylpropionates / pharmacology*
-
Structure-Activity Relationship
Substances
-
2-(3-(3,4-bis(benzyloxy)phenyl)acryloyloxy)-3-(3,4-dimethoxyphenyl)propanoic acid
-
Acrylates
-
Matrix Metalloproteinase Inhibitors
-
Phenylpropionates
-
Matrix Metalloproteinase 1